Cargando…
Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity
PURPOSE: Corneal opacity and neovascularization (NV) are often described as outcomes of severe herpes simplex virus type 1 (HSV-1) infection. The current study investigated the role of colony-stimulating factor 1 receptor (CSF1R)(+) cells and soluble factors in the progression of HSV-1-induced corne...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441335/ https://www.ncbi.nlm.nih.gov/pubmed/32785676 http://dx.doi.org/10.1167/iovs.61.10.24 |
_version_ | 1783573277953753088 |
---|---|
author | Filiberti, Adrian Gmyrek, Grzegorz B. Montgomery, Micaela L. Sallack, Renee Carr, Daniel J. J. |
author_facet | Filiberti, Adrian Gmyrek, Grzegorz B. Montgomery, Micaela L. Sallack, Renee Carr, Daniel J. J. |
author_sort | Filiberti, Adrian |
collection | PubMed |
description | PURPOSE: Corneal opacity and neovascularization (NV) are often described as outcomes of severe herpes simplex virus type 1 (HSV-1) infection. The current study investigated the role of colony-stimulating factor 1 receptor (CSF1R)(+) cells and soluble factors in the progression of HSV-1-induced corneal NV and opacity. METHODS: MaFIA mice were infected with 500 plaque-forming units of HSV-1 in the cornea following scarification. From day 10 to day 13 post-infection (pi), mice were treated with 40 µg/day of AP20187 (macrophage ablation) or vehicle intraperitoneally. For osteopontin (OPN) neutralization experiments, C57BL/6 mice were infected as above and treated with 2 µg of goat anti-mouse OPN or isotypic control IgG subconjunctivally every 2 days from day 4 to day 12 pi. Mice were euthanized on day 14 pi, and tissue was processed for immunohistochemistry to quantify NV and opacity by confocal microscopy and absorbance or detection of pro- and anti-angiogenic and inflammatory factors and cells by suspension array analysis and flow cytometry, respectively. RESULTS: In the absence of CSF1R(+) cells, HSV-1-induced blood and lymphatic vessel growth was muted. These results correlated with a loss in fibroblast growth factor type 2 (FGF-2) and an increase in OPN expression in the infected cornea. However, a reduction in OPN expression in mice did not alter corneal NV but significantly reduced opacity. CONCLUSIONS: Our data suggest that CSF1R(+) cell depletion results in a significant reduction in HSV-1-induced corneal NV that correlates with the loss of FGF-2 expression. A reduction in OPN expression was aligned with a significant drop in opacity associated with reduced corneal collagen disruption. |
format | Online Article Text |
id | pubmed-7441335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-74413352020-08-31 Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity Filiberti, Adrian Gmyrek, Grzegorz B. Montgomery, Micaela L. Sallack, Renee Carr, Daniel J. J. Invest Ophthalmol Vis Sci Immunology and Microbiology PURPOSE: Corneal opacity and neovascularization (NV) are often described as outcomes of severe herpes simplex virus type 1 (HSV-1) infection. The current study investigated the role of colony-stimulating factor 1 receptor (CSF1R)(+) cells and soluble factors in the progression of HSV-1-induced corneal NV and opacity. METHODS: MaFIA mice were infected with 500 plaque-forming units of HSV-1 in the cornea following scarification. From day 10 to day 13 post-infection (pi), mice were treated with 40 µg/day of AP20187 (macrophage ablation) or vehicle intraperitoneally. For osteopontin (OPN) neutralization experiments, C57BL/6 mice were infected as above and treated with 2 µg of goat anti-mouse OPN or isotypic control IgG subconjunctivally every 2 days from day 4 to day 12 pi. Mice were euthanized on day 14 pi, and tissue was processed for immunohistochemistry to quantify NV and opacity by confocal microscopy and absorbance or detection of pro- and anti-angiogenic and inflammatory factors and cells by suspension array analysis and flow cytometry, respectively. RESULTS: In the absence of CSF1R(+) cells, HSV-1-induced blood and lymphatic vessel growth was muted. These results correlated with a loss in fibroblast growth factor type 2 (FGF-2) and an increase in OPN expression in the infected cornea. However, a reduction in OPN expression in mice did not alter corneal NV but significantly reduced opacity. CONCLUSIONS: Our data suggest that CSF1R(+) cell depletion results in a significant reduction in HSV-1-induced corneal NV that correlates with the loss of FGF-2 expression. A reduction in OPN expression was aligned with a significant drop in opacity associated with reduced corneal collagen disruption. The Association for Research in Vision and Ophthalmology 2020-08-12 /pmc/articles/PMC7441335/ /pubmed/32785676 http://dx.doi.org/10.1167/iovs.61.10.24 Text en Copyright 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Immunology and Microbiology Filiberti, Adrian Gmyrek, Grzegorz B. Montgomery, Micaela L. Sallack, Renee Carr, Daniel J. J. Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity |
title | Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity |
title_full | Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity |
title_fullStr | Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity |
title_full_unstemmed | Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity |
title_short | Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity |
title_sort | loss of osteopontin expression reduces hsv-1-induced corneal opacity |
topic | Immunology and Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441335/ https://www.ncbi.nlm.nih.gov/pubmed/32785676 http://dx.doi.org/10.1167/iovs.61.10.24 |
work_keys_str_mv | AT filibertiadrian lossofosteopontinexpressionreduceshsv1inducedcornealopacity AT gmyrekgrzegorzb lossofosteopontinexpressionreduceshsv1inducedcornealopacity AT montgomerymicaelal lossofosteopontinexpressionreduceshsv1inducedcornealopacity AT sallackrenee lossofosteopontinexpressionreduceshsv1inducedcornealopacity AT carrdanieljj lossofosteopontinexpressionreduceshsv1inducedcornealopacity |